Business Context and Reporting Period
This Form 6-K filing by SciSparc Ltd. (SPRC) covers the month of September 2023, with the report dated September 21, 2023. The Company is a foreign private issuer headquartered in Tel Aviv, Israel, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a corporate action regarding the Company's capital structure rather than financial performance results.
Material Changes
The primary material change announced is a reverse share split of the Company's issued and outstanding ordinary shares at a ratio of 1-for-26. Key details include:
- Effective Date: Trading on a split-adjusted basis on the Nasdaq Capital Market is expected to begin on Thursday, September 28, 2023.
- Share Symbol: The Company will continue to trade under the symbol "SPRC".
- Fractional Shares: No fractional shares will be issued. Fractional shares are rounded up to the nearest whole share; only shareholders holding fractional consolidated shares of one-half or more are entitled to receive one consolidated share.
- Authorized Capital: The authorized share capital remains unchanged at 75,000,000 Ordinary Shares.
- Derivatives: A proportionate adjustment will be made to the per-share exercise price and the number of shares issuable upon the exercise of all outstanding options or warrants.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the timing of the reverse share split. Management notes that actual results may differ materially from expectations due to inherent uncertainties. The Company explicitly disclaims any obligation to update these forward-looking statements except as required by applicable securities laws. Investors are directed to the Company's Annual Report on Form 20-F filed on May 1, 2023, for a detailed description of risks and uncertainties.
Investor Verification Checklist
- Confirm the exact date trading begins on a split-adjusted basis (expected September 28, 2023).
- Verify the treatment of fractional shares in the Company's Articles of Association (rounding up for holdings of 0.5 or more).
- Check the adjusted exercise prices and share counts for any outstanding options or warrants held.
- Review the Annual Report on Form 20-F (filed May 1, 2023) for comprehensive risk factors.